Royal Bank Of Canada Transcode Therapeutics, Inc. Transaction History

Royal Bank Of Canada

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$1.01 - $952.0 $86 - $81,872	86 New	86 $0
Q1 2022 May 16, 2022	SELL	$2.03 - $3.01 $99 - $147	-49 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$2.42 - $3.41 $118 - $167	49 New	49 $0

6.5K

Ticker RNAZ
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 12,977,200
Market Cap $4.02M
Description
TransCode Therapeutics, Inc., a biopharmaceutical company, engages in the development and commercialization of drugs and diagnostics for treating and identifying metastatic disease. Its lead therapeutic candidate, TTX-MC138, is a preclinical stage product for the treatment of metastatic cancer. The company's products in preclinical programs incl...

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

Stay updated on Royal Bank Of Canada with notifications on news.